Efficacy of total skin electron beam therapy in early stages t1-2 mycosis fungoides : results of a long-term follow-up

Author(s):  
T Gilles ◽  
Y Loı̈c ◽  
D Sophie ◽  
L Daniel ◽  
P Tony ◽  
...  
2021 ◽  
Vol 2021 ◽  
pp. 1-3
Author(s):  
Eric Bessell ◽  
Martin Dalton ◽  
John David Parry

A man now aged 80 years has received specialist care for stage 1A mycosis fungoides for 58 years. The disease developed in childhood. Long-term follow-up (>30 years) of patients with mycosis fungoides is infrequently described in the world literature. The disease in this patient was limited to 5 areas, but these were large (up to 25 cm in diameter). The rest of the skin was normal clinically. All 5 areas were treated separately with electron beam therapy (3–4 MeV) to a dose of 30 Gy in 15 fractions over 3 weeks between 2000 and 2005. Complete regression was obtained in all 5 areas, and the patient has been in complete remission for 15 years after living with the disease previously for over 40 years.


2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e18511-e18511
Author(s):  
Miroslav Lutsyk ◽  
Orit Kaidar-Person ◽  
Micha Bar-Hanna ◽  
Yoram Cohen ◽  
Abraham Kuten

e18511 Background: Mycosis fungoides (MF) and Sezary's syndrome are the most common subgroup of cutaneous T-cell lymphoma. Total or partial skin electron beam irradiation (TSEI, PSEI) is an accepted treatment option in cases of disease that is limited to the skin and as palliative treatment in advanced disease. Consequently, long term follow-up of these patients and detection of secondary malignancies after TSEI/PSEI is crucial. The aim of this study was to summarize long term follow-up of MF patients treated by TSEI or PSEI and to evaluate the rates of secondary malignancies. Methods: A retrospective review of the medical charts of all consecutive patients diagnosed with MF who was treated from January 1960 to June 2010 at our hospital was conducted. Data collected included demographics, date of diagnosis, staging, treatment, and secondary malignancies. Results: One hundred ninety six patients were included (132 M, 64 F). The median age at diagnosis was 67.3 years. The mean follow-up was 109.4±89.4 months (range 1-566). One hundred patients received TSEI, 45 patients received PSEI, and one patient was treated by low dose total body photon irradiation combined with TSEI. Fifty patients (50/196, 25.5%) developed a second malignancy, 16 patients (16/196, 8%) had a third malignancy, and 4 (2%) patients developed a fourth malignancy. Conclusions: MF is associated with development of sequential malignancies. The contribution of TSEI or PSEI to the development of secondary malignancies is yet to be determined. Long term follow-up in this group of patients is essential.


1995 ◽  
Vol 33 (2) ◽  
pp. 234-242 ◽  
Author(s):  
James J Herrmann ◽  
Henry H Roenigk ◽  
Arti Hurria ◽  
Timothy M Kuzel ◽  
Ellen Samuelson ◽  
...  

2015 ◽  
Vol 51 ◽  
pp. S653
Author(s):  
S. Laskar ◽  
C. Hotwani ◽  
T. Wadasadawala ◽  
N. Khanna ◽  
J. Sastri ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document